Division of Psychosocial Research and Epidemiology The Netherlands Cancer Institute Amsterdam the Netherlands.
Julius Center for Health Sciences and Primary Care University Medical Center UtrechtUtrecht University Utrecht The Netherlands.
J Am Heart Assoc. 2021 Sep 7;10(17):e021580. doi: 10.1161/JAHA.121.021580. Epub 2021 Sep 2.
Background Physical exercise is an intervention that might protect against doxorubicin-induced cardiotoxicity. In this meta-analysis and systematic review, we aimed to estimate the effect of exercise on doxorubicin-induced cardiotoxicity and to evaluate mechanisms underlying exercise-mediated cardioprotection using (pre)clinical evidence. Methods and Results We conducted a systematic search in PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Cochrane's and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk-of-bias tools were used to assess the validity of human and animal studies, respectively. Cardiotoxicity outcomes reported by ≥3 studies were pooled and structured around the type of exercise intervention. Forty articles were included, of which 3 were clinical studies. Overall, in humans (sample sizes ranging from 24 to 61), results were indicative of exercise-mediated cardioprotection, yet they were not sufficient to establish whether physical exercise protects against doxorubicin-induced cardiotoxicity. In animal studies (n=37), a pooled analysis demonstrated that forced exercise interventions significantly mitigated in vivo and ex vivo doxorubicin-induced cardiotoxicity compared with nonexercised controls. Similar yet slightly smaller effects were found for voluntary exercise interventions. We identified oxidative stress and related pathways, and less doxorubicin accumulation as mechanisms underlying exercise-induced cardioprotection, of which the latter could act as an overarching mechanism. Conclusions Animal studies indicate that various exercise interventions can protect against doxorubicin-induced cardiotoxicity in rodents. Less doxorubicin accumulation in cardiac tissue could be a key underlying mechanism. Given the preclinical evidence and limited availability of clinical data, larger and methodologically rigorous clinical studies are needed to clarify the role of physical exercise in preventing cardiotoxicity in patients with cancer. Registration URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42019118218.
体育锻炼是一种可能预防多柔比星诱导性心脏毒性的干预措施。在本次荟萃分析和系统评价中,我们旨在评估运动对多柔比星诱导性心脏毒性的影响,并使用(临床前)证据评估运动介导的心脏保护作用的机制。
我们在 PubMed、Embase 和 Cochrane 对照试验中心注册库(CENTRAL)数据库中进行了系统检索。分别使用 Cochrane 偏倚风险工具和系统评价中心用于动物实验的偏倚风险工具(SYRCLE)评估了人类和动物研究的有效性。汇总了报告≥3 项研究的心脏毒性结局,并围绕运动干预类型进行了结构分析。共纳入 40 篇文章,其中 3 篇为临床研究。总体而言,在人类(样本量范围为 24 至 61 例)中,结果表明运动介导的心脏保护作用,但不足以确定体育锻炼是否能预防多柔比星诱导的心脏毒性。在动物研究中(n=37),一项汇总分析表明,与未运动对照组相比,强制运动干预显著减轻了体内和体外多柔比星诱导的心脏毒性。自愿运动干预也发现了类似但稍小的效果。我们确定了氧化应激和相关途径以及多柔比星在心脏组织中积累较少是运动诱导心脏保护的作用机制,其中后者可能作为一个总体机制发挥作用。
动物研究表明,各种运动干预措施可预防多柔比星诱导的啮齿动物心脏毒性。心脏组织中多柔比星积累减少可能是一个关键的潜在机制。鉴于临床前证据和临床数据的有限可用性,需要进行更大规模且方法学上更严格的临床试验,以阐明体育锻炼在预防癌症患者心脏毒性中的作用。